This inventor holds 1 USPTO granted patent. Top assignee: Kao Corporation. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: **Eisaku Yoshida: Innovator in Macrophage Chemotactic Peptides**
Introduction
Eisaku Yoshida is a notable inventor based in Tochigi, Japan, recognized for his innovative contributions to the field of biochemistry. With a singular patent to his name, Yoshida has made strides in the development of peptides that exhibit significant physiological activities, particularly in macrophage chemotactic properties.
Latest Patents
Yoshida's patent, titled "Novel peptides possessing a macrophage chemotactic activity," focuses on the discovery of novel peptides characterized by a specific amino acid sequence that enhances macrophage chemotaxis. This invention holds potential implications for therapeutic applications in conditions where immune response modulation is critical.
Career Highlights
Eisaku Yoshida is affiliated with Kao Corporation, a leading company in the sphere of personal care and chemical products. His role at Kao Corporation allows him to engage in pioneering research, furthering the understanding of biologically active peptides and their possible utility in various medical applications.
Collaborations
During his career, Yoshida has collaborated with esteemed colleagues, including Toshiaki Osawa and Naonobu Yoshizuka. These partnerships have contributed to the advancement of research and development within the organization, highlighting the importance of teamwork in innovation.
Conclusion
Eisaku Yoshida's work exemplifies the impact that dedicated inventors can have on science and industry. His focus on macrophage chemotactic peptides showcases the potential for innovations that not only enhance our understanding of immune function but also pave the way for future therapeutic interventions. With his continuous contributions, Yoshida is a significant figure in the ongoing dialogue of biochemistry and patent innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
